Abstract
Despite the advent of a novel human papillomavirus (HPV) vaccine to prevent associated cancers, HPV vaccination rates in the United States (US) remain well below national goals. Two recent reports by the Centers for Disease Control and Prevention (CDC) and the President's Cancer Panel (PCP) have identified missed clinical opportunities as an intervention point for increasing HPV vaccination rates, including the provision of immunization in alternative venues by varying healthcare providers. In this paper, we specifically comment on the idea of offering HPV vaccination in emergency departments (ED) by emergency medicine (EM) physicians as posited by Hill and Okugo (2014), identifying both strengths and limitations to this strategy. We also offer ideas for additional research, suggest provider and healthcare systems changes, and discuss needed policy changes to improve HPV vaccination rates in the US.
| Original language | English |
|---|---|
| Article number | A9 |
| Pages (from-to) | 2559-2561 |
| Number of pages | 3 |
| Journal | Human Vaccines and Immunotherapeutics |
| Volume | 10 |
| Issue number | 9 |
| DOIs | |
| State | Published - Sep 1 2014 |
Bibliographical note
Publisher Copyright:© 2014 Taylor & Francis Group, LLC
Keywords
- Alternative settings
- Emergency departments
- HPV vaccination
- Missed clinical appointments
- Physicians
- Policy
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Pharmacology
